Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
Integra LifeSciences Holdings Corporation (IART) is set to release its fourth quarter and full year 2023 financial results on February 28, 2024. The management team will host a conference call at 8:30 a.m. ET, with a live webcast available on the Investors section of the company's website. Participants can register for the call and access dial-in details. A webcast replay will also be available on the Investors section of the website.
02/07/2024 - 09:15 AM
PRINCETON, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2023 financial results on Wednesday, February 28, 2024, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com . For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com .
Investor Relations: Chris Ward (609) 772-7736chris.ward@integralife.com
Media Contact: Laurene Isip (609) 208-8121laurene.isip@integralife.com
When will Integra LifeSciences Holdings Corporation release its fourth quarter and full year 2023 financial results?
Integra LifeSciences Holdings Corporation will release its fourth quarter and full year 2023 financial results on February 28, 2024.
What time will the conference call for the earnings release take place?
The conference call for the earnings release will take place at 8:30 a.m. ET.
Where can I access the live webcast for the earnings release?
The live webcast for the earnings release will be available on the Investors section of the Company’s website at investor.integralife.com.
How can I register to participate in the conference call?
Participants can register for the conference call and receive dial-in details by visiting the Company’s website.
Will there be a webcast replay available for the conference call?
Yes, a webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.
Integra Lifesciences Holdings Corp
IART Rankings
#3952 Ranked by Stock Gains
IART Stock Data
Industry
Analytical Laboratory Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Analytical Laboratory Instrument Manufacturing
Country
US
City
Princeton
About IART
integra lifesciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. in the united states, integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. founded in 1989 integra is headquartered in plainsboro, new jersey and has over 3,500 employees worldwide. integra's common stock is li